The role of prostate needle biopsy in evaluation of chemopreventive agents
- 1 April 2001
- Vol. 57 (4) , 191-193
- https://doi.org/10.1016/s0090-4295(00)00972-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PAIN AND MORBIDITY OF TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY: A PROSPECTIVE RANDOMIZED TRIAL OF 6 VERSUS 12 CORESJournal of Urology, 2000
- CHEMOPREVENTION OF UROLOGICAL CANCERJournal of Urology, 1999
- alpha 1-ADRENOCEPTOR ANTAGONISTS TERAZOSIN AND DOXAZOSIN INDUCE PROSTATE APOPTOSIS WITHOUT AFFECTING CELL PROLIFERATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1999
- Long-term effects of finasteride on prostate tissue compositionUrology, 1999
- Histological Changes in Benign Prostate Biopsies Following Long-Term Finasteride Therapy for Prostatic HyperplasiaJournal of Urologic Pathology, 1999
- Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening programUrology, 1997
- Prostate Tissue Composition and Response to Finasteride in Men With Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1997
- Systematic Sextant Biopsies in 651 Patients Referred for Prostate EvaluationJournal of Urology, 1994
- Morbidity with Contemporary Prostate BiopsyJournal of Urology, 1993
- Random Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the ProstateJournal of Urology, 1989